2021-03-13T00:00:02+00:00

Sanofi announced the launch of human trials of its second Covid-19 vaccine

French pharmaceutical firm Sanofi announced Friday the launch of human trials of its second Covid-19 vaccine. Sanofi and the US-based company Translate Bio are developing the vaccine based on messenger RNA (mRNA) technology.

Sanofi's Chief Executive Paul Hudson told French newspaper Le Journal du Dimanche last month that the vaccine "will not be ready this year."

The company's first vaccine, developed with GlaxoSmithKline (GSK), is still in the testing phase. Both companies are attempting to revive their development after earlier tests showed in December, a low immune response in older adults.

Sources: Content Sources

Source: Deutsche Welle

Image Source

Sanofi

Pentributor:

Érico Andrei

@ericof

Co-founder of Pendect, passionate about open source and knowledge sharing. Made in Mooca.

Card reviewed by: @christoph

Categorization: Locations & Places

France

Organizations & Institutions

Cookies🍪

Our website uses scripts, such as cookies, to technically provide the site ("essential scripts") and third-party website tracking technologies to provide and continually improve our services and display advertisements based on the perceived interests of users. By clicking the "Accept All" button, the website visitor agrees to the activation of all scripts. Essential cookies are also executed without the consent. The consent can be revoked or changed at any time with effect for the future. By clicking the "Reject" button, only essential cookies are used. In our data protection policy, we provide detailed information about the type and scope of data processing.

Accept All Reject